A Cancer Vaccine (CG8123) Given With and Without Cyclophosphamide for Advanced Stage Non-Small Cell Lung Cancer (NSCLC)

Clinical trial NCT00089726 · COMPLETED

Trial details

NCT number: NCT00089726
Sponsor: Cell Genesys
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer Carcinoma, Non-Small-Cell Lung

Start date: 2003-03-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.